USC.edu
Are You a Patient?

Charite N. Ricker, MS, CGC

Assistant Professor Of Clinical Medicine

Image of Charite N. Ricker, MS, CGC
Is this your profile? Click to edit
Phone +1 323 409 7710
Email [email protected]
CTSI Profile

Overview

Charité Ricker, MS is a genetic counselor with the USC Norris Comprehensive Cancer Center and Clinical Instructor of Medicine in the USC Keck School of Medicine. She leads the genetic counseling team at Los Angeles General Medical Center for individuals and family at risk of having inherited cancer syndromes.

Ms. Ricker has extensive experience as a cancer genetic counselor and the majority of her clinical work has been in the underserved patient setting. Her particular research interest is focused on the provision of genetic services to ethnically diverse patient populations and its impact and the outcomes.

Research Funding

  • Increasing Access to Genetic Testing in Underserved Patients Using a Multilingual Conversational Agent
    NIH · R01CA263532 · Jun 1, 2022 – May 31, 2026 · Role: Principal Investigator

Publications

  • Psychosocial outcomes following germline multigene panel testing in an ethnically and economically diverse cohort of patients. Cancer. 2021 04 15; 127(8):1275-1285.. View in PubMed
  • PD-1 inhibition therapy for advanced cutaneous squamous cell carcinoma: a retrospective analysis from the University of Southern California. J Cancer Res Clin Oncol. 2021 Jun; 147(6):1803-1811.. View in PubMed
  • Inhibition of poly(ADP-ribose) polymerase induces synthetic lethality in BRIP1 deficient ovarian epithelial cells. Gynecol Oncol. 2020 12; 159(3):869-876.. View in PubMed
  • BRCA1/2 mutations and risk-reducing bilateral salpingo-oophorectomy among Latinas: The UPTAKE study. J Genet Couns. 2021 04; 30(2):383-393.. View in PubMed
  • A pilot randomized trial of an educational intervention to increase genetic counseling and genetic testing among Latina breast cancer survivors. J Genet Couns. 2021 04; 30(2):394-405.. View in PubMed
  • Management of Male Breast Cancer: ASCO Guideline. J Clin Oncol. 2020 06 01; 38(16):1849-1863.. View in PubMed
  • Two synchronous malignancies: nodular melanoma and renal cell carcinoma in a patient with an underlying germline BRCA2 mutation. BMJ Case Rep. 2019 Jun 20; 12(6).. View in PubMed
  • Pathogenic and likely pathogenic variants in PALB2, CHEK2, and other known breast cancer susceptibility genes among 1054 BRCA-negative Hispanics with breast cancer. Cancer. 2019 08 15; 125(16):2829-2836.. View in PubMed
  • Multicenter Prospective Cohort Study of the Diagnostic Yield and Patient Experience of Multiplex Gene Panel Testing For Hereditary Cancer Risk. JCO Precis Oncol. 2019 Mar; 3.. View in PubMed
  • Clinical findings and outcomes of MRI staging of breast cancer in a diverse population. Breast Cancer Res Treat. 2019 Apr; 174(2):315-324.. View in PubMed

Similar People